tanezumab
FDA lifts ban on Pfizer Lilly pain study
March 24, 2015Research and Development, Sales and Marketing Cancer, FDA, Pfizer, lilly, pain, tanezumab
Pfizer and Eli Lilly will resume Phase III clinical trials of tanezumab following the FDA lifting a ban on trials …
Pfizer forced to halt pain drug trials
July 20, 2010Research and Development Pfizer, chronic pain, pain therapeutics, tanezumab
Pfizer has been told by the FDA to suspend trials of its novel injectable biotherapeutic tanezumab for chronic low back …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
